Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Testing mAbs generated by the PCRP pipeline in ChIP-seq application

ABSTRACT: We report the applicability of multiple PCRP mAbs in ChIP-seq applications in human cell-lines using standard ENCODE protocols.

ORGANISM(S): Homo sapiens

PROVIDER: GSE97661 | GEO | 2017/04/12

SECONDARY ACCESSION(S): PRJNA382581

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Determination of specificity of the MAbs to Der p 21

Project description:For determination of specificity of the MAbs, rDer p 21, thermally denatured rDer p 21 and rMBP-Der p 21 (0.3 mg/mL) were printed. the slides were incubated for 2 h 5 different MAbs (0.5 µg/mL for specificity analysis). Then the slides were incubated for 30 min goat anti-mouse IgG Fc Alexa Fluor® 647. Human serum albumin, rMBP, HRP and PBS were printed as negative controls.

2023-12-25 | E-MTAB-13625 | biostudies-arrayexpress

Transcriptional signature of human mesoangioblasts from different fetal tissues.

Project description:Purpose: We performed comparative transcriptome analysis of mesoangioblasts (MABs) derived from different cardiovascular or skeletal muscle tissues to determine possible gene signatures underlying their specific differentation capacities and define future appropriate cell therapy applications. Methods: RNA was extracted from human fetal mesoangioblasts derived from Aorta, Atrium, Ventricle and Skeletal muscle (Ao, A, V and Sk) in proliferative conditions. Deep sequencing was used to determine quantitative gene expression between the different cell populations. Results: MABs derived from different tissues show differences in their transcriptome profile, despite their common ebryologic origin and isolation using common caracterization markers. The expression by Sk MABs of key cardiogenic genes (i.e. Isl1, TBX2) and the identification of active signaling pathways will serve for future skeletal to cardiac differentiation protocols. Conclusion: Cardiogenic Sk MABs may thus represent a easily accessible cell source for cardiac regeneration.

2020-02-11 | GSE90069 | GEO

Research and development of therapeutic mAbs: An analysis based on pipeline projects.

Project description:As the subject of active research and development (R&D) in recent decades, monoclonal antibodies have emerged among the major classes of therapeutic agents for treatment of many human diseases, especially cancers, infections, and immunological disorders. This article surveys the landscape of R&D projects of therapeutic monoclonal antibodies (mAbs), which are mostly used for disease immunotherapy, from a number of perspectives, including therapeutic indications, development phases, participants, and citation of related patents. The results of this research can be used as a reference resource for pharmaceutical researchers, investors, and policymakers in the field of therapeutic mAbs.

| S-EPMC4916486 | biostudies-literature

Differential regulation patterns of anti-CD20 mAbs in MCL

Project description:We investigated the differential regulation patterns of type I anti-CD20 monoclonal antibody (mAb) rituximab and type II obinutuzumab on a transcriptional level. Using a panel of MCL cell lines, we determined the effects of obinutuzumab and rituximab as monotherapies as well as in combination on cell viability and proliferation. Obinutuzumab induced a higher reduction in cell proliferation in each mantle cell lymphoma cell line than rituximab did. Results indicate a common pattern of expression changes after binding of anti-CD20 mAbs, but also reveal a significant difference between type I and type II treatment. Combination treatment resulted in a rituximab-like expression pattern. Many deregulated genes were associated with stress signalling, cell death, immune response and other functional clusters. Our analyses identified different and antibody-specific downstream expression patterns of obinutuzumab and rituximab, which may represent the molecular basis of the superior effect of obinutuzumab in comparison to rituximab.

2014-12-31 | GSE54169 | GEO

novel mAbs sequencing through LC and CE

Project description:In this research, capillary electrophoresis was combined with liquid chromatography to sequence novel monoclonal antibodies. It was demonstrated CE can provide highly complemetary information to LC in the process of novel mAbs sequencing.

2020-04-21 | MSV000085317 | MassIVE

Single-cell profiling of histone modifications and transcription in developmental systems with EpiDamID [RPE1]

Project description:We developed EpiDamID, an adaptation of existing DamID protocols that extends their applicability to histone PTMs.

2022-04-01 | GSE196959 | GEO

Single-cell profiling of histone modifications and transcription in developmental systems with EpiDamID [zebrafish]

Project description:We developed EpiDamID, an adaptation of existing DamID protocols that extends their applicability to histone PTMs.

2022-04-01 | GSE184035 | GEO

Single-cell profiling of histone modifications and transcription in developmental systems with EpiDamID [mouse ESC]

Project description:We developed EpiDamID, an adaptation of existing DamID protocols that extends their applicability to histone PTMs.

2022-04-01 | GSE184034 | GEO

Single-cell profiling of histone modifications and transcription in developmental systems with EpiDamID [mouse EB]

Project description:We developed EpiDamID, an adaptation of existing DamID protocols that extends their applicability to histone PTMs.